Table 1.
Characteristics | PENFS Treatment (n = 12) | Standard Therapy Control (n = 9) | P Value |
---|---|---|---|
Age, mean years | 50 ± 9.78 | 48.56 ± 10.08 | 0.68 |
Gender | |||
Female | 6 (50%) | 6 (67%) | 0.47 |
Male | 6 (50%) | 3 (33%) | — |
Race | |||
Caucasian | 7 (58%) | 4 (44%) | 0.55 |
African American | 5 (42%) | 5 (56%) | — |
Ethnicity | |||
Hispanic | 1 (9%) | 1 (11%) | 0.84 |
Non-Hispanic | 10 (83%) | 8 (89%) | — |
Unknown | 1 (8%) | 0 (0%) | — |
Baseline pain scores, mean DVPRS | 6.42 ± 1.64 | 8 ± 1.52 | 0.04* |
Baseline sit-to-stand | 8.67 ± 4.48 | 6.44 ± 3.21 | 0.22 |
Baseline bicep curls | |||
Left | 18.92 ± 7.20 | 15.33 ± 7.66 | 0.29 |
Right | 18.58 ± 6.51 | 14.89 ± 7.27 | 0.24 |
PENFS = percutaneous electrical nerve field stimulation; DVPRS = Defense and Veterans Pain Rating Scale.
P<0.05. Means are reported with 95% confidence intervals (mean ± 1.96 standard deviation).